BR9908610A - Composto, processo para produzir o mesmo, composição farmacêutica, uso do composto, processos par ainibir a produção de óxido nìtrico e/ou citocina em mamìferos, e para impedir ou tratar doença cardìaca, doença autoimune ou choque séptico em mamìferos, e, pró medicamentos - Google Patents
Composto, processo para produzir o mesmo, composição farmacêutica, uso do composto, processos par ainibir a produção de óxido nìtrico e/ou citocina em mamìferos, e para impedir ou tratar doença cardìaca, doença autoimune ou choque séptico em mamìferos, e, pró medicamentosInfo
- Publication number
- BR9908610A BR9908610A BR9908610-7A BR9908610A BR9908610A BR 9908610 A BR9908610 A BR 9908610A BR 9908610 A BR9908610 A BR 9908610A BR 9908610 A BR9908610 A BR 9908610A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- mammals
- optionally
- hydrocarbon group
- substituents
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 241000124008 Mammalia Species 0.000 title abstract 3
- 208000019622 heart disease Diseases 0.000 title abstract 3
- 208000023275 Autoimmune disease Diseases 0.000 title abstract 2
- 102000004127 Cytokines Human genes 0.000 title abstract 2
- 108090000695 Cytokines Proteins 0.000 title abstract 2
- 206010040070 Septic Shock Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000036303 septic shock Effects 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000002483 medication Methods 0.000 title 1
- 125000001424 substituent group Chemical group 0.000 abstract 6
- 125000001931 aliphatic group Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 206010025482 malaise Diseases 0.000 abstract 4
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Silicon Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
Abstract
"COMPOSTO, PROCESSO PARA PRODUZIR O MESMO, COMPOSIçãO FARMACêUTICA, USO DO COMPOSTO, PROCESSOS PARA INIBIR A PRODUçãO DE óXIDO NìTRICO E/OU CITOCINA EM MAMìFEROS, E PARA IMPEDIR OU TRATAR DOENçA CARDìACA, DOENçA AUTOIMUNE OU CHOQUE SéPTICO EM MAMìFEROS, E, PRó MEDICAMENTO". A presente invenção fornece um composto representado pela fórmula: em que R representa um grupo hidrocarboneto alifático que tenha opcionalmente substituintes, um grupo hidrocarboneto aromático que tenha opcionalmente substituintes, um grupo heterocíclico que tenha opcionalmente substituintes, um grupo representado pela fórmula: OR¹ (em que R¹ representa um átomo de hidrogênio ou um grupo hidrocarboneto alifático que tenha opcionalmente substituintes) ou um grupo representado pela fórmula: em que R^ 1b^ representa um átomo de hidrogênio ou um grupo hidrocarboneto alifático que tenha opcionalmente substituintes, R^ 1c^ é o mesmo como R^ 1b^ ou diferente dele, um átomo de hidrogênio ou um grupo hidrocarboneto alifático que tenha opcionalmente substituintes, R^ 0^ representa um átomo de hidrogênio ou um grupo hidrocarboneto alifático, ou R e R^ 0^ representam uma ligação um com o outro, Ar representa um grupo hidrocarboneto aromático que tenha opcionalmente substituintes, e n é um número inteiro de 1 a 4, ou um sal deste, que é um agente para prevenir ou tratar doenças tais como doença cardíaca, doença autoimune, choque séptico, etc.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5649298 | 1998-03-09 | ||
| JP28436298 | 1998-10-06 | ||
| PCT/JP1999/001103 WO1999046242A1 (en) | 1998-03-09 | 1999-03-08 | Cycloalkene derivatives, process for producing the same, and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9908610A true BR9908610A (pt) | 2000-12-05 |
Family
ID=26397446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9908610-7A BR9908610A (pt) | 1998-03-09 | 1999-03-08 | Composto, processo para produzir o mesmo, composição farmacêutica, uso do composto, processos par ainibir a produção de óxido nìtrico e/ou citocina em mamìferos, e para impedir ou tratar doença cardìaca, doença autoimune ou choque séptico em mamìferos, e, pró medicamentos |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6495604B1 (pt) |
| EP (2) | EP1524263A1 (pt) |
| JP (2) | JP3665712B2 (pt) |
| KR (4) | KR100577044B1 (pt) |
| CN (1) | CN100432049C (pt) |
| AT (1) | ATE287393T1 (pt) |
| AU (1) | AU747521B2 (pt) |
| BR (1) | BR9908610A (pt) |
| CA (1) | CA2320467C (pt) |
| DE (1) | DE69923300T2 (pt) |
| DK (1) | DK1063228T5 (pt) |
| ES (1) | ES2232114T3 (pt) |
| HU (1) | HU230061B1 (pt) |
| ID (1) | ID25649A (pt) |
| NO (1) | NO326426B1 (pt) |
| NZ (1) | NZ505874A (pt) |
| PT (1) | PT1063228E (pt) |
| RU (1) | RU2214398C2 (pt) |
| WO (1) | WO1999046242A1 (pt) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9908610A (pt) | 1998-03-09 | 2000-12-05 | Takeda Chemical Industries Ltd | Composto, processo para produzir o mesmo, composição farmacêutica, uso do composto, processos par ainibir a produção de óxido nìtrico e/ou citocina em mamìferos, e para impedir ou tratar doença cardìaca, doença autoimune ou choque séptico em mamìferos, e, pró medicamentos |
| US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
| AU6471200A (en) * | 1999-08-06 | 2001-03-05 | Takeda Chemical Industries Ltd. | Substituted aromatic-ring compounds, process for producing the same, and use |
| AU1553001A (en) * | 1999-11-29 | 2001-06-12 | Takeda Chemical Industries Ltd. | Process for the production of optically active cyclohexene derivatives and intermediates therefor |
| KR100784752B1 (ko) * | 2000-02-04 | 2007-12-13 | 다케다 야쿠힌 고교 가부시키가이샤 | 안정한 에멀젼 조성물 |
| JP4863553B2 (ja) * | 2000-02-04 | 2012-01-25 | 武田薬品工業株式会社 | 安定な乳化組成物 |
| US6951885B2 (en) | 2000-08-10 | 2005-10-04 | Takeda Pharmaceutical Company Limited | Pharmaceutical composition |
| JP4922507B2 (ja) * | 2000-08-10 | 2012-04-25 | 武田薬品工業株式会社 | 医薬組成物 |
| US6982344B2 (en) | 2000-10-18 | 2006-01-03 | Takeda Pharmaceutical Company Limited | Process for preparation of optically active sulfonamides and intermediates for their synthesis |
| AU2002221099A1 (en) * | 2000-12-08 | 2002-06-18 | Takeda Chemical Industries Ltd. | Combination drugs |
| ATE442143T1 (de) | 2001-03-21 | 2009-09-15 | Eisai R&D Man Co Ltd | Reduziertes vitamin b2 enthaltende arzneimittel |
| EP1420783A4 (en) * | 2001-08-03 | 2009-09-30 | Takeda Pharmaceutical | STABLE EMULSION COMPOSITION |
| WO2003084527A1 (en) * | 2002-04-08 | 2003-10-16 | Takeda Chemical Industries, Ltd. | Severe sepsis preventive therapeutic agent |
| JP4824576B2 (ja) * | 2003-12-03 | 2011-11-30 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | サイトカイン生成のインヒビターとしての１，２，３−トリアゾールアミド誘導体 |
| TWI462745B (zh) * | 2005-04-28 | 2014-12-01 | Takeda Pharmaceutical | 安定的乳化組成物 |
| CA2622694C (en) * | 2005-09-14 | 2011-02-08 | Daiichi Sankyo Company, Limited | Substituted cycloalkene derivative |
| US8329420B2 (en) | 2006-03-30 | 2012-12-11 | Hiroshima University | Screening method for a substance that binds to an intracellular region of TLR4 |
| EP2260869A3 (en) | 2006-04-20 | 2011-03-23 | Takeda Pharmaceutical Company Limited | Pharmaceutical product |
| WO2007132825A1 (ja) | 2006-05-15 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 医薬 |
| EP2039681A4 (en) | 2006-07-07 | 2009-10-28 | Takeda Pharmaceutical | CYCLOALKENE DERIVATIVES, PROCESS FOR PRODUCTION OF DERIVATIVES, AND USE THEREOF |
| JP2008260760A (ja) * | 2007-03-12 | 2008-10-30 | Daiichi Sankyo Co Ltd | 置換シクロアルケン誘導体を含有する医薬組成物 |
| ME02364B (me) | 2010-01-27 | 2016-06-20 | Takeda Pharmaceuticals Co | Jedinjenja za supresiju poremećaja perifernih nerava indukovanih anti-kancerogenim sredstvom |
| JP5778161B2 (ja) | 2010-09-24 | 2015-09-16 | 第一三共株式会社 | 置換シクロアルケン誘導体の結晶 |
| EP2866565A4 (en) * | 2012-07-03 | 2016-04-13 | Jay Pravda | METHOD FOR TREATING, DIAGNOSIS AND / OR MONITORING THE PROGRESSION OF OXO ASSOCIATED STATES |
| WO2014050910A1 (ja) | 2012-09-26 | 2014-04-03 | 武田薬品工業株式会社 | 固体粒子の製造方法 |
| AR104539A1 (es) | 2015-05-08 | 2017-07-26 | Takeda Pharmaceuticals Co | Compuestos cíclicos |
| EP3511320A4 (en) | 2016-09-09 | 2020-04-15 | Takeda Pharmaceutical Company Limited | CYCLIC CONNECTION |
| WO2018156297A1 (en) * | 2017-02-24 | 2018-08-30 | Taiwanj Pharmaceuticals Co., Ltd | Sulfonamide or amide compounds, compositions and methods for the prophylaxis and/or treatment of autoimmune, inflammation or infection related disorders |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU217808B (hu) | 1990-11-06 | 2000-04-28 | Nippon Shinyaku Co., Ltd. | Eljárás liofilizált készítmény előállítására |
| AU653279B2 (en) * | 1991-12-30 | 1994-09-22 | Sanofi | Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| US5576016A (en) | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
| EP0746318A1 (en) | 1994-02-25 | 1996-12-11 | Takeda Chemical Industries, Ltd. | Injectable emulsions containing antifungal triazole derivatives |
| AU3230895A (en) * | 1994-08-18 | 1996-03-14 | Chugai Seiyaku Kabushiki Kaisha | Amino acid derivative having nitrogen monoxide synthetase inhibitor activity |
| JPH08109165A (ja) * | 1994-08-18 | 1996-04-30 | Chugai Pharmaceut Co Ltd | 一酸化窒素合成酵素阻害作用を有するアミノ酸誘導体 |
| BR9908610A (pt) | 1998-03-09 | 2000-12-05 | Takeda Chemical Industries Ltd | Composto, processo para produzir o mesmo, composição farmacêutica, uso do composto, processos par ainibir a produção de óxido nìtrico e/ou citocina em mamìferos, e para impedir ou tratar doença cardìaca, doença autoimune ou choque séptico em mamìferos, e, pró medicamentos |
| KR100784752B1 (ko) | 2000-02-04 | 2007-12-13 | 다케다 야쿠힌 고교 가부시키가이샤 | 안정한 에멀젼 조성물 |
-
1999
- 1999-03-08 BR BR9908610-7A patent/BR9908610A/pt not_active IP Right Cessation
- 1999-03-08 CN CNB998029521A patent/CN100432049C/zh not_active Expired - Lifetime
- 1999-03-08 US US09/622,392 patent/US6495604B1/en not_active Expired - Lifetime
- 1999-03-08 DK DK99907879T patent/DK1063228T5/da active
- 1999-03-08 DE DE69923300T patent/DE69923300T2/de not_active Expired - Lifetime
- 1999-03-08 RU RU2000125568/04A patent/RU2214398C2/ru not_active IP Right Cessation
- 1999-03-08 EP EP05000768A patent/EP1524263A1/en not_active Withdrawn
- 1999-03-08 KR KR1020057001729A patent/KR100577044B1/ko not_active Expired - Fee Related
- 1999-03-08 KR KR1020057011882A patent/KR20050071719A/ko not_active Ceased
- 1999-03-08 AT AT99907879T patent/ATE287393T1/de active
- 1999-03-08 KR KR10-2000-7009764A patent/KR100492098B1/ko not_active Expired - Lifetime
- 1999-03-08 PT PT99907879T patent/PT1063228E/pt unknown
- 1999-03-08 ES ES99907879T patent/ES2232114T3/es not_active Expired - Lifetime
- 1999-03-08 ID IDW20001736A patent/ID25649A/id unknown
- 1999-03-08 EP EP99907879A patent/EP1063228B1/en not_active Expired - Lifetime
- 1999-03-08 AU AU27464/99A patent/AU747521B2/en not_active Ceased
- 1999-03-08 WO PCT/JP1999/001103 patent/WO1999046242A1/ja not_active Ceased
- 1999-03-08 JP JP05963099A patent/JP3665712B2/ja not_active Expired - Lifetime
- 1999-03-08 CA CA2320467A patent/CA2320467C/en not_active Expired - Fee Related
- 1999-03-08 NZ NZ505874A patent/NZ505874A/en not_active IP Right Cessation
- 1999-03-08 HU HU0101192A patent/HU230061B1/hu not_active IP Right Cessation
- 1999-03-08 KR KR1020067001730A patent/KR100779889B1/ko not_active Expired - Fee Related
-
2000
- 2000-09-08 NO NO20004485A patent/NO326426B1/no not_active IP Right Cessation
-
2005
- 2005-02-02 JP JP2005026914A patent/JP4342453B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9908610A (pt) | Composto, processo para produzir o mesmo, composição farmacêutica, uso do composto, processos par ainibir a produção de óxido nìtrico e/ou citocina em mamìferos, e para impedir ou tratar doença cardìaca, doença autoimune ou choque séptico em mamìferos, e, pró medicamentos | |
| DK0583421T3 (da) | Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse | |
| BRPI0418148A (pt) | composto, prodroga de um composto, modulador da função do receptor gpr40, agente farmacêutico, uso de um composto e métodos de modificação de uma função do receptor gpr40 em um mamìfero, de profilaxia ou tratamento de diabetes em um mamìfero e de produção de um composto | |
| ATE271128T1 (de) | Inhibitoren der il-6 aktivitaet | |
| PT652868E (pt) | Inibidores da fosfodiesterase do amp ciclico | |
| BR0213455A (pt) | Composto, seu uso, composição farmacêutica, método para o tratamento ou prevenção de uma doença para a qual um receptor adenosina está relacionado, e método para promover a defecação | |
| DK1060163T3 (da) | Nye piperazinyl-substituerede pyridylalkan-, -alken og -alkyncarboxamider | |
| ZA9811240B (en) | New aryl-substituted pyridylalkane alkene and alkine carboxamides | |
| MX9301214A (es) | 1-alcoxi-2-(alcoxi-o cicloalquiloxi)-4-(ciclotioalquil o ciclotioalquenil-)benceno, proceso para su preparacion y composicion farmaceutica que lo co ntiene. | |
| PT1042315E (pt) | Piridilalcano alceno e alcino carboxamidas imido-substituidas ciclicas uteis como agentes citoestacticos e imunossupressores | |
| ES2106531T3 (es) | Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso. | |
| BRPI0411221A (pt) | composto, medicamento, métodos para inibir a produção de citocinas inflamatórias, e para a prevenção ou tratamento de doenças associadas com citocinas inflamatórias, método para o tratamento ou alìvio de febre, dor e/ou inflamação e, métodos para a prevenção ou tratamento de artrite reumatóide, de osteoartrite, de doença septicêmica, psorìase, doença de crohn, colite ulcerativa, diabete melito ou, hepatite | |
| HUP0103203A2 (hu) | Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| DE69715891D1 (de) | Pyrazolopyridinverbindung und seine pharmazeutische verwendung | |
| DE69418744D1 (de) | Verwendung von Pregnanderivaten zur Behandlung von Tumoren | |
| KR940702726A (ko) | 치환된 퀴놀린-3-카르복시아미드 화합물의 용도 및 이를 이용한 다발성 경화증의 치료방법 | |
| ATE151597T1 (de) | Fungizide verbindungen | |
| TW200510379A (en) | 1, 4-disubstituted piperidine compounds, their preparation and use as medicaments | |
| KR930703013A (ko) | 항당뇨병제로서 유용한 신규한 글루코하이드롤라제 억제제 | |
| KR960021021A (ko) | 인터루킨-1β의 생성 및 종양 괴사 인자 α의 방출을 억제하기 위한 약제 | |
| TH37815A (th) | อนุพันธ์ 6,5-เฮทเทอโร-ไปไซคลิก ที่ถูกแทนที่ | |
| TH64560A (pt) | ||
| TH13819A (th) | สารต้านไวรัส | |
| ATE275576T1 (de) | Ungesättigte 14,15-cyclopropano-androstane, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| TH18027A (th) | อนุพันธ์ของอีพอกซิซัคฟินิคแอซิด |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) Free format text: NOME ALTERADO DE: TAKEDA CHEMICAL INDUSTRIES, LTD. |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO DE ACORDO COM ( ART. 8O E ART. 11 DA LPI |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 18A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |